safety of glp-1 receptor agonists Understanding and their impact on drug discovery There has been a drug
Description
Back Mojsov, S, Weir, GC, Habener, JF (Feb 1987) 'Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas', Journal of Clinical Investigation , 79, 616-19
B.et al (2017)
Because GLP-1 receptor agonists are therapeutic peptides, treatment with these agents has the potential to lead to the development of anti-drug antibodies
It also decreases your stomach acid, which then can lead to problems like heartburn, indigestion after eating food sensitivities, as well as increasing your risk for SIBO or candida
